Aspirin and Ibuprofen: Why Timing Can Be Formulation-Specific

Aspirin and ibuprofen are both over-the-counter NSAIDs, and both FDA labels document that ibuprofen can interfere with aspirin's antiplatelet effect. What they do not support is a single, universal "wait N hours" rule -- the real timing relationship depends on which aspirin product is involved and which drug is taken first.

The documented finding

See the full aspirin and ibuprofen interaction record for sources. In short: ibuprofen and aspirin compete for the same binding site on platelet COX-1. If ibuprofen occupies that site first, it can reversibly block aspirin's access, blunting aspirin's irreversible antiplatelet effect -- the effect people taking daily low-dose aspirin for heart attack or stroke protection are relying on.

Why formulation and order both matter

One aspirin label (DURLAZA, an extended-release product) gives a dosing-timing instruction specific to that formulation. A separate ibuprofen label's own pharmacodynamic studies show the relationship is more nuanced for aspirin generally: dosing ibuprofen at least 2 hours after immediate-release low-dose aspirin largely preserved aspirin's antiplatelet effect in the underlying study, while dosing ibuprofen before aspirin, or using enteric-coated aspirin at all, did not reliably avoid the interference regardless of timing tested.

That is the reason this site does not display one universal spacing interval for this pair -- doing so would overstate what the combined evidence actually supports across every aspirin product and dosing order.

What to do

Never stop or change a cardioprotective aspirin regimen based on this site. Check your specific combination and ask your pharmacist or clinician about the correct sequencing for your specific aspirin product (immediate-release vs. enteric-coated) before regularly combining it with ibuprofen or another NSAID.

See NSAIDs and Blood Pressure or Blood-Thinning Medicines for how NSAIDs interact with other medication classes, and Medication Safety for more medication-focused guidance.